Pubertal Blockade and Subsequent Gender-Affirming Therapy
- 1 November 2022
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 5 (11) , e2239763
Abstract
For youth who identify as transgender or are unsure and wish to explore possibilities before the development of permanent secondary sex characteristics, use ofKeywords
This publication has 9 references indexed in Scilit:
- Association of Gonadotropin-Releasing Hormone Analogue Use With Subsequent Use of Gender-Affirming Hormones Among Transgender AdolescentsJAMA Network Open, 2022
- Bone Health Among Transgender Youth: What Is a Clinician to Do?Pediatrics, 2021
- Addressing Legislation That Restricts Access to Care for Transgender YouthPediatrics, 2021
- Ensuring Comprehensive Care and Support for Transgender and Gender-Diverse Children and AdolescentsPediatrics, 2018
- Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice GuidelineYearbook of Paediatric Endocrinology, 2018
- Long-Term Effects of Gonadotropin-Releasing Hormone Agonists and Add-Back in Adolescent EndometriosisJournal of Pediatric and Adolescent Gynecology, 2018
- Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline (vol 102, pg 3869, 2017)The Journal of Clinical Endocrinology & Metabolism, 2018
- Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2017
- The Efficacy and Safety of Gonadotropin-Releasing Hormone Analog Treatment in Childhood and Adolescence: A Single Center, Long-Term Follow-Up StudyThe Journal of Clinical Endocrinology & Metabolism, 2010